⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4139743 | 1.00 | LMNA (0.40) | — | |
| SCHEMBL19411337 | 1.00 | LMNA (0.40) | — | |
| SCHEMBL19411336 | 1.00 | LMNA (0.40) | — | |
| SCHEMBL11144733 | 1.00 | LMNA (0.40) | — | |
| SCHEMBL272453 | 1.00 | — | — | |
| SCHEMBL8973807 | 1.00 | LMNA (0.40) | — | |
| SCHEMBL4133064 | 0.97 | — | — | |
| SCHEMBL274098 | 0.86 | — | — | |
| SCHEMBL2904875 | 0.86 | — | — | |
| SCHEMBL11567726 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302194-A1 | Biomedical Polyurethanes | POLYGANICS IP B.V. (NL) | 2023-09-28 | — | — | US | claimed |
| EP-3436091-B1 | IMPROVED BIOMEDICAL POLYURETHANES | POLYGANICS IP B V (NL) | 2020-03-11 | — | — | EP | claimed |
| US-20190099518-A1 | Improved Biomedical Polyurethanes | POLYGANICS IP B.V. (NL) | 2019-04-04 | — | — | US | claimed |
| US-20230302194-A1 | Biomedical Polyurethanes | POLYGANICS IP B.V. (NL) | 2023-09-28 | — | — | US | disclosed |
| US-11633517-B2 | Biomedical polyurethanes | POLYGANICS IP B.V. (NL) | 2023-04-25 | — | — | US | disclosed |
| EP-3687588-B1 | TISSUE-ADHESIVE SEALANT DEVICE | POLYGANICS IP B V (NL) | 2022-07-20 | — | — | EP | disclosed |
| US-11160900-B2 | Tissue-adhesive sealant device | POLYGANICS IP B.V. (NL) | 2021-11-02 | — | — | US | disclosed |
| US-20200261615-A1 | Tissue-Adhesive Sealant Device | POLYGANICS IP B.V. (NL) | 2020-08-20 | — | — | US | disclosed |
| EP-3687588-A2 | TISSUE-ADHESIVE SEALANT DEVICE | Polyganics IP B.V. (NL) | 2020-08-05 | — | — | EP | disclosed |
| EP-3436091-B1 | IMPROVED BIOMEDICAL POLYURETHANES | POLYGANICS IP B V (NL) | 2020-03-11 | — | — | EP | disclosed |
| WO-2019066657-A2 | TISSUE-ADHESIVE SEALANT DEVICE | POLYGANICS IP B.V. (NL) | 2019-04-04 | — | — | WO | disclosed |
| US-20190099518-A1 | Improved Biomedical Polyurethanes | POLYGANICS IP B.V. (NL) | 2019-04-04 | — | — | US | disclosed |
| EP-3436091-A1 | IMPROVED BIOMEDICAL POLYURETHANES | Polyganics IP B.V. (NL) | 2019-02-06 | — | — | EP | disclosed |
| WO-2017171550-A1 | IMPROVED BIOMEDICAL POLYURETHANES | POLYGANICS IP B.V. (NL) | 2017-10-05 | — | — | WO | disclosed |
| EP-0882714-B1 | SUBSTITUTED VINYLPYRIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME | SS PHARMACEUTICAL CO (JP) | 2004-03-03 | — | — | EP | disclosed |
| US-5935977-A | PHOSPHODIESTERASE IV INHIBITORS, TUMOR NECROSIS FACTOR-ALPHA PRODUCTION INHIBITORS; TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES | SS PHARMACEUTICAL CO., LTD. (JP) | 1999-08-10 | — | — | US | disclosed |
| EP-0882714-A1 | SUBSTITUTED VINYLPYRIDINE DERIVATIVES AND DRUGS CONTAINING THE SAME | SS Pharmaceutical Co., Ltd. (JP) | 1998-12-09 | — | — | EP | disclosed |